1 mg equals 1000 mcg
Given this unifying pathophysiology, GLP-1 RAs, with their powerful ability to act both centrally (controlling appetite and cravings) and peripherally (correcting systemic metabolic dysfunction, resolving hepatic steatosis and inflammation), to exert direct anti-carcinogenic effects, represent a truly multi-functional therapeutic tool
For Wegovy (higher-dose semaglutide for weight management), rates were higher, affecting approximately 29.3% of patients across the STEP clinical trials, with most cases occurring during dose escalation phases
Retatrutide peptide works by activating three hormone receptor systems involved in glucose control, appetite, and energy balance [1], [2]
Kidney problems can occur without symptoms until the condition is at an advanced stage with limited treatment options